Article: DeCode Cuts Work Force, Signs Multimillion-Dollar Merck Deal.

Staff Writer

The cutbacks just keep coming at biotechnology companies.

On Friday, DeCode genetics Inc. said it is eliminating nearly a third of its work force, or about 200 employees, as part of a plan to achieve positive cash flow in the next year. The Reykjavik, Iceland-based firm said the move would allow it to fund operations solely through revenue generated by its product-driven genetics research and service businesses, which includes contract chemistry services, pharmacogenomics and informatics.

DeCode also should earn some extra funds from a newly reported deal with Merck & Co. Inc., an alliance disclosed the same day aimed at developing ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!